Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

MicroRNA binding-site polymorphisms as potential biomarkers of cancer risk.

Blitzblau RC, Weidhaas JB.

Mol Diagn Ther. 2010 Dec 1;14(6):335-42. doi: 10.2165/11587600-000000000-00000. Review.

PMID:
21275451
2.

MicroRNA binding site polymorphisms as biomarkers of cancer risk.

Pelletier C, Weidhaas JB.

Expert Rev Mol Diagn. 2010 Sep;10(6):817-29. doi: 10.1586/erm.10.59.

3.

SNPs in microRNA binding sites as prognostic and predictive cancer biomarkers.

Preskill C, Weidhaas JB.

Crit Rev Oncog. 2013;18(4):327-40. Review.

4.

Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer.

Slaby O, Bienertova-Vasku J, Svoboda M, Vyzula R.

J Cell Mol Med. 2012 Jan;16(1):8-21. doi: 10.1111/j.1582-4934.2011.01359.x. Review.

5.

Single-nucleotide polymorphisms among microRNA: big effects on cancer.

Song FJ, Chen KX.

Chin J Cancer. 2011 Jun;30(6):381-91. Review.

6.

Role of variations within microRNA-binding sites in cancer.

Landi D, Gemignani F, Landi S.

Mutagenesis. 2012 Mar;27(2):205-10. doi: 10.1093/mutage/ger055.

PMID:
22294768
7.

Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.

Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G, Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GA.

Cancer Res. 2010 Apr 1;70(7):2789-98. doi: 10.1158/0008-5472.CAN-09-3541. Epub 2010 Mar 23.

8.

Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.

Liang D, Meyer L, Chang DW, Lin J, Pu X, Ye Y, Gu J, Wu X, Lu K.

Cancer Res. 2010 Dec 1;70(23):9765-76. doi: 10.1158/0008-5472.CAN-10-0130. Epub 2010 Nov 30.

9.

Polymorphisms of microRNA sequences or binding sites and lung cancer: a meta-analysis and systematic review.

Chen Z, Xu L, Ye X, Shen S, Li Z, Niu X, Lu S.

PLoS One. 2013 Apr 16;8(4):e61008. doi: 10.1371/journal.pone.0061008. Print 2013. Review.

10.

The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes.

Teo MT, Landi D, Taylor CF, Elliott F, Vaslin L, Cox DG, Hall J, Landi S, Bishop DT, Kiltie AE.

Carcinogenesis. 2012 Mar;33(3):581-6. doi: 10.1093/carcin/bgr300. Epub 2011 Dec 12.

11.

A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck.

Liu H, Gao F, Dahlstrom KR, Li G, Sturgis EM, Zevallos JP, Wei Q, Liu Z.

Tumour Biol. 2016 Jun;37(6):8057-66. doi: 10.1007/s13277-015-4682-6. Epub 2015 Dec 28.

12.

A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer.

Lee SY, Choi JE, Jeon HS, Hong MJ, Choi YY, Kang HG, Yoo SS, Lee EB, Jeong JY, Lee WK, Lee J, Cha SI, Kim CH, Kim YT, Jheon S, Son JW, Park JY.

Ann Oncol. 2015 Jun;26(6):1142-8. doi: 10.1093/annonc/mdv100. Epub 2015 Feb 24.

PMID:
25716425
13.

Screening SNPs residing in the microRNA-binding sites of hepatocellular carcinoma related genes.

Ding J, Gao Y, He Y, Zhou Y, Huang M, Liu H.

Int J Data Min Bioinform. 2011;5(1):1-21.

PMID:
21491841
14.

Inferring single nucleotide polymorphisms in microRNA binding sites of lung cancer-related inflammatory genes.

He F, Zheng LL, Luo WT, Yang R, Xu XQ, Cai L.

Asian Pac J Cancer Prev. 2014;15(8):3601-6.

15.

Single nucleotide polymorphisms in microRNA binding sites of oncogenes: implications in cancer and pharmacogenomics.

Manikandan M, Munirajan AK.

OMICS. 2014 Feb;18(2):142-54. doi: 10.1089/omi.2013.0098. Epub 2013 Nov 28.

16.

miRNA polymorphisms and risk of gastric cancer in Asian population.

Hua HB, Yan TT, Sun QM.

World J Gastroenterol. 2014 May 21;20(19):5700-7. doi: 10.3748/wjg.v20.i19.5700. Review.

17.

Evaluation of genetic variants in microRNA biosynthesis genes and risk of breast cancer in Chinese women.

Jiang Y, Chen J, Wu J, Hu Z, Qin Z, Liu X, Guan X, Wang Y, Han J, Jiang T, Jin G, Zhang M, Ma H, Wang S, Shen H.

Int J Cancer. 2013 Nov;133(9):2216-24. doi: 10.1002/ijc.28237. Epub 2013 Jul 11.

18.

Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.

Bagheri F, Mesrian Tanha H, Mojtabavi Naeini M, Ghaedi K, Azadeh M.

Mol Med Rep. 2016 May;13(5):4494-8. doi: 10.3892/mmr.2016.5078. Epub 2016 Mar 31.

PMID:
27035115
19.

Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding.

Dzikiewicz-Krawczyk A, Macieja A, Mały E, Januszkiewicz-Lewandowska D, Mosor M, Fichna M, Strauss E, Nowak J.

J Hematol Oncol. 2014 Jun 2;7:43. doi: 10.1186/1756-8722-7-43.

20.

Micromarkers 2.0: an update on the role of microRNAs in cancer diagnosis and prognosis.

Ferracin M, Negrini M.

Expert Rev Mol Diagn. 2015;15(10):1369-81. doi: 10.1586/14737159.2015.1081058. Epub 2015 Sep 4. Review.

PMID:
26338209

Supplemental Content

Support Center